SOLS Solstice Advanced Materials Inc.
Chemicals & Allied Products · Nasdaq · SEC CIK 2064953 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY9.4%
TTM net income YoY-1.2%
TTM EPS YoY-1.6%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin30.9%
Operating margin—
Net margin7.8%
FCF margin10.7%
EBITDA margin—
Returns
ROE13.6%
ROA5.7%
ROIC (approx.)—
Asset turnover0.74x
Leverage & solvency
Liabilities / assets74.1%
Debt / equity1.26x
Current ratio1.38x
Interest coverage—
Cash quality & payout
Operating cash flow / net income2.64x
Accruals ratio-9.4%
Payout ratio472.6%
Capex / revenue9.9%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 |
|---|---|---|---|
| Income statement | |||
| Revenue | $3.89B | $3.77B | $3.65B |
| Cost of revenue | $2.64B | $2.46B | $2.37B |
| Gross profit | $1.25B | $1.31B | $1.28B |
| R&D expense | $97.00M | $83.00M | $81.00M |
| SG&A expense | $421.00M | $392.00M | $378.00M |
| Interest expense | $28.00M | $13.00M | $16.00M |
| Pretax income | $647.00M | $797.00M | $814.00M |
| Income tax | $362.00M | $192.00M | $195.00M |
| Net income | $237.00M | $594.00M | $621.00M |
| EPS (basic) | 1.49 | 3.74 | 3.91 |
| EPS (diluted) | 1.49 | 3.74 | 3.91 |
| Weighted avg. shares (diluted) | 158.90M | 158.70M | 158.70M |
| Balance sheet | |||
| Cash & equivalents | $534.00M | $661.00M | $606.00M |
| Receivables | $645.00M | $569.00M | — |
| Inventory | $715.00M | $558.00M | — |
| Current assets | $2.39B | $1.86B | — |
| PP&E, net | $2.06B | $1.75B | — |
| Goodwill | $820.00M | $806.00M | $814.00M |
| Intangibles | $49.00M | $35.00M | — |
| Total assets | $5.67B | $5.00B | — |
| Current liabilities | $1.71B | $1.08B | — |
| Short-term debt | $4.00M | $0 | — |
| Long-term debt | $1.97B | $0 | — |
| Total debt | $1.97B | $0 | — |
| Total liabilities | $4.30B | $1.82B | — |
| Shareholders' equity | $1.41B | $3.26B | $3.03B |
| Net debt | $1.44B | -$661.00M | — |
| Shares outstanding | 158.75M | 0 | — |
| Cash flow statement | |||
| Operating cash flow | $455.00M | $842.00M | $760.00M |
| Capital expenditure | $336.00M | $296.00M | $299.00M |
| Free cash flow | $119.00M | $546.00M | $461.00M |
| Investing cash flow | -$330.00M | -$298.00M | -$324.00M |
| Financing cash flow | -$235.00M | -$453.00M | -$378.00M |
| Depreciation & amortization | $24.00M | $39.00M | $48.00M |
| Stock-based compensation | $27.00M | $17.00M | $18.00M |
| Dividends paid | $1.50B | $0 | $0 |
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.